يحاول ذهب - حر
MedTech's sustainability mission
June 2024
|BioSpectrum Asia
MedTech, not unlike other industries, hurts the environment and must find ways to mitigate this harm. Several leading top medtech companies have announced environmental, social, and governance (ESG) goals. What steps are medtech companies taking to improve sustainability and how much further do they need to go to make a dent in carbon emissions? Let's dig deeper.
 
 Health care accounts for 5 per cent of total global carbon emissions, and medical devices and technology are responsible for a large portion of that, according to Boston Consulting Groups (BCG). Much of this comes from the manufacturing operations and supply chains of medtech companies and their suppliers. At the provider level, MedTech generates tonnes of unrecycled waste through single-use disposable products and packaging.
Stringent regulations
Regulators worldwide are also establishing rules requiring companies to publish standardised ESG information. In Europe, regulations are already in place. In the US, proposed new disclosure requirements for public companies focus on climate-related risks and relevant risk management processes. Another key ESG trend is the mandatory sustainability reporting obligations imposed on companies globally. In the Asia-Pacific region, ESG regulation is accelerating due to the urgent need for greater transparency and tightened definitions for sustainable investment products. The twofold increase in the number of ESG policies in the region over the past five years has led to increased corporate ESG disclosure across most APAC markets, which now align with or exceed those in the US, says Goldman Sachs report.
The Australian government plans to introduce mandatory climate-related financial disclosure requirements, encouraging companies to adopt more environmentally responsible practices. Moreover, stringent waste disposal regulations are on the horizon, with Japan aiming to cut plastic waste by 25 per cent and South Korea by 50 per cent, both by 2030. In light of all this, the medtech industry and the broader healthcare sector are increasingly committing to environmental stewardship.
Cutting carbon footprints
هذه القصة من طبعة June 2024 من BioSpectrum Asia.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من BioSpectrum Asia
 
 BioSpectrum Asia
India signs MoU with Pfizer to strengthen healthcare innovation ecosystem
In a significant step towards strengthening India's healthcare innovation ecosystem, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, has signed a Memorandum of Understanding (MoU) with US-based Pfizer Limited.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
New Zealand to lead new gene therapy trial for muscular dystrophy
The first clinical trial of a new treatment for a rare form of muscular dystrophy is being led by New Zealand-based University of Auckland's Centre for Brain Research.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
Scientists in Australia grow living skin in world-first
Australia's University of Queensland (UQ) researchers have been the first in the world to successfully grow fully functioning human skin in a laboratory.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
India joins Health AI Global Regulatory Network to strengthen oversight of AI in healthcare
HealthAI - The Global Agency for Responsible AI in Health, has welcomed India as a pioneer country joining the HealthAI Global Regulatory Network (GRN), a global network of health regulators dedicated to the safe and effective use of artificial intelligence (AI) in healthcare.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
TVM Capital Healthcare announces first closing of $150 M Southeast Asia Fund
Singapore-based TVM Capital Healthcare, a global private equity investor and operator specialised in healthcare growth capital across emerging markets, has announced the first closing of its $150 million TVM Healthcare Southeast Asia Fund (SEA Fund).
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
National Yang Ming Chiao Tung University, TSH Biopharm collaborate to foster pharma talent in Taiwan
Taiwan's National Yang Ming Chiao Tung University (NYCU) and TSH Biopharm have signed a five-year industry-academia collaboration Memorandum of Understanding (MOU).
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
Fujifilm Biosciences introduces BalanCD HEK293 Perfusion A Medium
Fujifilm Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market, has announced the commercial launch of BalanCD HEK293 Perfusion A.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
Korea makes smart patch that can run tests using sweat instead of blood
A research team at Korea Advanced Institute of Science and Technology has developed a smart patch that can precisely observe internal changes through sweat when simply attached to the body.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
ADB approves $106.9 M to strengthen secondary healthcare services in Sri Lanka
The Asian Development Bank (ADB) has approved a $106.9 million financing package to strengthen Sri Lanka's secondary curative care services, improve communicable disease prevention and control, and enhance the healthcare sector's governance and management capacity.
1 min
BioSpectrum Asia Oct 2025
 
 BioSpectrum Asia
Epigenic Therapeutics raises $60 M to accelerate clinical development of medicines
China-based startup Epigenic Therapeutics, a clinical-stage innovative drug development company, has announced the completion of a $60 million Series B round of financing led by Lapam Capital, with continued participation from existing investors Qiming Venture Partners and OrbiMed, and addition of new investors including IFSC and a renowned investment firm in the industry.
1 min
BioSpectrum Asia Oct 2025
Listen
Translate
Change font size

